Biocon

In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)

Biocon has featured on the Science Top Employers list of the world’s pre-eminent pharma, biotech, and biopharma employers for 11…

In this video, Arun Anand, COO, Immuneel Therapeutics and Dr Bruce Levine, of the University of Pennsylvania Perelman School of…

Liraglutide is a drug-device combination for the treatment and management of Type 2 diabetes and obesity

Bains has accordingly stepped down from his role on the Biocon Board as an Independent Director with immediate effect, to assume…

The RCSed’s Court of Regents comprises a group of distinguished individuals in their field who provide the College with advice and…

The facility is acquired for a total consideration of $7.7 million

The company has also on-boarded global leadership talent across several functions including Manufacturing Science and Technology…

YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema…

HULIO is available at a list price (wholesale acquisition cost) of five per cent below the current Humira list price.…